Evidence map›Paper›PMID 32326763›Full record

ArticleFree radical research2020

Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.

Brian Fink, Lawrence Coppey, Eric Davidson, Hanna Shevalye, Alexander Obrosov, Pratik Rajesh Chheda, Robert Kerns, William Sivitz, Mark Yorek

Open access · greenAbstract read
In one paragraph

Article in Free radical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Repair of Corneal Epithelial Defects.Progress in molecular and subcellular biology · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brian FinkDepartment of Veterans Affairs, Iowa City Health Care System, Iowa City, IA, USA.
Lawrence CoppeyDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Eric DavidsonDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Hanna ShevalyeDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Alexander ObrosovDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Pratik Rajesh ChhedaCollege of Pharmacy, University of Iowa, Iowa City, IA, USA.
Robert KernsCollege of Pharmacy, University of Iowa, Iowa City, IA, USA.
William SivitzDepartment of Veterans Affairs, Iowa City Health Care System, Iowa City, IA, USA.
Mark YorekDepartment of Veterans Affairs, Iowa City Health Care System, Iowa City, IA, USA.
University of Iowa · USIowa City VA Health Care System · USFraternal Order of Eagles · US

Funding

Targeting Mitochondrial Fission for Neuroprotection in Diabetic NeuropathyR01DK116624 · NIDDK · UNIVERSITY OF IOWA · PI STRACK, STEFAN, USACHEV, YURIY M · 2018 to 2021
$2.1M
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetateR01DK123043 · NIDDK · UNIVERSITY OF IOWA · PI SIVITZ, WILLIAM IRVING · 2020 to 2023
$1.3M
Effect of exogenous fatty acids on diabetes neural/neurovascular complicationsR01DK107399 · NIDDK · UNIVERSITY OF IOWA · PI YOREK, MARK A. · 2016 to 2019
$1.1M
Diabetic Neuropathy: Function-Structure of Corneal Nerves to Assess Injury-RepairI01RX000889 · VA · IOWA CITY VA MEDICAL CENTER · PI KARDON, RANDY H., YOREK, MARK A. · 2015 to 2022
–
NIDDK NIH HHS R01 DK107399NIDDK NIH HHS R01 DK116624NIDDK NIH HHS R01 DK123043RRD VA I01 RX000889
6 · The paper itself

Abstract

This study sought to determine whether the addition of mitoquinone (Mito-Q) in the diet is an effective treatment for peripheral neuropathy in animal models of diet-induced obesity (pre-diabetes) and type 2 diabetes. Unlike other anti-oxidative stress compounds investigated as a treatment for peripheral neuropathy, Mito-Q specifically targets mitochondria. Although mito-Q has been shown to reduce oxidative stress generated by mitochondria there have been no studies performed of the effect of Mito-Q on peripheral neuropathy induced by diet-induced obesity or type 2 diabetes. Diet-induced obese (12 weeks after high fat diet) or type 2 diabetic rats (12 weeks of high fat diet and 4 weeks after the onset of hyperglycemia) were treated

Indexed as

Disease Models, AnimalAnimalsAntioxidantsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diet, High-FatHypoglycemic AgentsMaleMitochondriaObesityOrganophosphorus CompoundsPeripheral Nervous System DiseasesRatsRats, Sprague-DawleyStreptozocinUbiquinoneAntioxidantsHypoglycemic AgentsmitoquinoneOrganophosphorus CompoundsStreptozocinUbiquinonediabetesmitoquinoneobesityoxidative stressPeripheral neuropathy

Identifiers

PMID32326763
PMCPMC7329571
OpenAlexW3018971322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.